FTLD involves one or more proteinopathies: 50% of FTD patients have aggregates of TAR DNA-binding protein 43 (TDP-43, FTLD-TDP) while 45% of FTD patients develops aggregates of the protein tau (Irwin et al., 2015). The gene discussed is MAPT; the disease is frontotemporal dementia.